Patrick Fleischmann de la Parra

Mr. Patrick Fleischmann de la Parra

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
Nadia RiveroNadia Rivero
Nadia Rivero
EZEmmanuel Alejandro Zepeda-Arzate
Emmanuel Alejandro Zepeda-Arzate
SCSelma Karime Castillo-Vazquez
Selma Karime Castillo-Vazquez
PPPatrick Fleischmann de la Parra
Patrick Fleischmann de la Parra
JHJessica Hernández-Pineda
Jessica Hernández-Pineda
CVCarlos Verjan
Carlos Verjan
Aging is the result of the accumulation of a wide variety of molecular and cellular damages over time, meaning that “the more damage we accumulate, the higher the possibility to develop age-related diseases”. Therefore, to reduce the incidence of such diseases and improve human health, it becomes important to find ways to combat such damage. In this sense, geroprotectors have been suggested as molecules that could slow down or prevent age-related diseases. On the other hand, nutraceuticals are another set of compounds that align with the need to prevent diseases and promote health since they are biologically active molecules (occurring naturally in food) that, apart from having a nutritional role, have preventive properties, such as antioxidant, anti-inflammatory and antitumoral, just to mention a few. Therefore, in the present review using the specialized databases Scopus and PubMed we collected information from articles published from 2010 to 2023 in order to describe the role of nutraceuticals during the aging process and, given their role in targeting the hallmarks of aging, we suggest that they are potential geroprotectors that could be consumed as part of our regular diet or administered additionally as nutritional supplements.

22 July 2021 in Proceedings of Scientific Research Universidad Anáhuac. Multidisciplinary Journal of Healthcare
Verified
Journal Article
Open access
PDF file
BJBethliza Alejandro Juárez
Bethliza Alejandro Juárez
PPPatrick Fleischmann de la Parra
Patrick Fleischmann de la Parra
KRKarla Tania Esmeralda Rayo-Mercado
Karla Tania Esmeralda Rayo-Mercado
TPTeresa Ponce-Lopez
Teresa Ponce-Lopez
La diabetes mellitus es un desorden metabólico crónico y complejo, caracterizado por hiperglicemia. Parte del tratamiento para este padecimiento es la administración de insulina, proteína que influye directamente en los niveles de glucosa en sangre. Tradicionalmente esta se administra de forma parenteral; sin embargo, en la actualidad existen formas alternativas para su aplicación que buscan mayor eficacia y menos invasividad. El objetivo del presente artículo es comparar los diferentes métodos de aplicación de la insulina, tomando en cuenta las nuevas tecnologías. Este artículo de revisión ofrece una descripción general de la diabetes y la insulina, destaca las ventajas y desventajas de los métodos de administración (subcutánea, inhalada, oral y bucal) y muestra las nuevas tecnologías que incluyen aplicaciones biotecnológicas.